Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Eli Lilly and Company .
Filed returns
7
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Eli Lilly and Company | Economic Development and Industry | EU and Irish life sciences policy development and competitiveness (Public policy or programme) | 9 | On lobbying.ie |
| May–Aug 2025 | Eli Lilly and Company | Trade | Discuss the risks of potential tariffs on the complex global supply chains for innovative medicines (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2025 | Eli Lilly and Company | EU Affairs | Advocate for improved EU Environment to support investment in medicines innovation and manufacturing (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2024 | Eli Lilly and Company | Economic Development and Industry | Project Progress and Economic Impact of Lilly Limerick. (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2024 | Eli Lilly and Company | Economic Development and Industry | Project Progress and Economic Impact of Lilly Limerick. (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2020 | Eli Lilly and Company | Health | Update on clinical research and product development carried out by Eli Lilly and Company with respect to treatments for Covid-19 (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2020 | Eli Lilly and Company | Economic Development and Industry | Definition of "Essential Work" under the Covid-19 Regulations and Restrictions. (Public policy or programme) | 4 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Economic Development and Industry | 4 | 57.1% | |
| EU Affairs | 1 | 14.3% | |
| Health | 1 | 14.3% | |
| Trade | 1 | 14.3% |